Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Maak

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
International Journal of Colorectal Disease|November 22, 2023
The role of intraoperative swab during appendectomy in patients with uncomplicated and complicated appendicitisBruno Leonardo Bancke Laverde, Matthias Maak, Melanie Langheinrich, et al.
Journal of Clinical Medicine|July 14, 2023
Risk Factors for Conversion from Laparoscopic to Open AppendectomyBruno Leonardo Bancke Laverde, Matthias Maak, Melanie Langheinrich, et al.
Annals of Surgery|November 2, 2010
The severity of neural invasion is a crucial prognostic factor in rectal cancer independent of neoadjuvant radiochemotherapyGüralp O Ceyhan, Florian Liebl, Matthias Maak, et al.
Molecular Cancer Therapeutics|January 31, 2016
Gastric Adenocarcinomas Express the Glycosphingolipid Gb3/CD77: Targeting of Gastric Cancer Cells with Shiga Toxin B-SubunitPhilipp Emanuel Geyer, Matthias Maak, Ulrich Nitsche, et al.
Annals of Surgery|December 19, 2008
Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time periodRobert Rosenberg, Jan Friederichs, Tibor Schuster, et al.
Molecular Cancer Therapeutics|July 27, 2011
Tumor-specific targeting of pancreatic cancer with Shiga toxin B-subunitMatthias Maak, Ulrich Nitsche, Larissa Keller, et al.
International Journal of Colorectal Disease|December 4, 2008
The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CTRobert Rosenberg, Ken Herrmann, Ralf Gertler, et al.
Annals of Surgery|January 9, 2013
Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancerMatthias Maak, Iris Simon, Ulrich Nitsche, et al.
Archives of Medical Science : AMS|February 28, 2024
Surgical and oncological outcome after extended lymph node dissection for carcinoma of the stomach and the esophagogastric junction: a retrospective analysis from an experienced single centerDimitrios Raptis, Matthias Maak, Christian Krautz, et al.
Annals of Surgery|August 31, 2013
Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosisUlrich Nitsche, Anina Zimmermann, Christoph Späth, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
International Journal of Colorectal Disease|November 22, 2023
The role of intraoperative swab during appendectomy in patients with uncomplicated and complicated appendicitisBruno Leonardo Bancke Laverde, Matthias Maak, Melanie Langheinrich, et al.
Journal of Clinical Medicine|July 14, 2023
Risk Factors for Conversion from Laparoscopic to Open AppendectomyBruno Leonardo Bancke Laverde, Matthias Maak, Melanie Langheinrich, et al.
Annals of Surgery|November 2, 2010
The severity of neural invasion is a crucial prognostic factor in rectal cancer independent of neoadjuvant radiochemotherapyGüralp O Ceyhan, Florian Liebl, Matthias Maak, et al.
Molecular Cancer Therapeutics|January 31, 2016
Gastric Adenocarcinomas Express the Glycosphingolipid Gb3/CD77: Targeting of Gastric Cancer Cells with Shiga Toxin B-SubunitPhilipp Emanuel Geyer, Matthias Maak, Ulrich Nitsche, et al.
Annals of Surgery|December 19, 2008
Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time periodRobert Rosenberg, Jan Friederichs, Tibor Schuster, et al.
Molecular Cancer Therapeutics|July 27, 2011
Tumor-specific targeting of pancreatic cancer with Shiga toxin B-subunitMatthias Maak, Ulrich Nitsche, Larissa Keller, et al.
International Journal of Colorectal Disease|December 4, 2008
The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CTRobert Rosenberg, Ken Herrmann, Ralf Gertler, et al.
Annals of Surgery|January 9, 2013
Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancerMatthias Maak, Iris Simon, Ulrich Nitsche, et al.
Archives of Medical Science : AMS|February 28, 2024
Surgical and oncological outcome after extended lymph node dissection for carcinoma of the stomach and the esophagogastric junction: a retrospective analysis from an experienced single centerDimitrios Raptis, Matthias Maak, Christian Krautz, et al.
Annals of Surgery|August 31, 2013
Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosisUlrich Nitsche, Anina Zimmermann, Christoph Späth, et al.
Pageof 5